Gemcitabine Hydrochloride, Dasatinib, and Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Is Metastatic or Cannot Be Removed by Surgery
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Centre Antoine Lacassagne
Thomas Jefferson University
M.D. Anderson Cancer Center
UNC Lineberger Comprehensive Cancer Center
Astellas Pharma Inc
OHSU Knight Cancer Institute
National Cancer Institute (NCI)
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
University of California, San Diego
Barbara Ann Karmanos Cancer Institute
M.D. Anderson Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Albert Einstein College of Medicine
Canadian Cancer Trials Group
University of Cincinnati
Alliance for Clinical Trials in Oncology
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Hoffmann-La Roche
Milton S. Hershey Medical Center
University of California, San Francisco
Astellas Pharma Inc
Astellas Pharma Inc
University of California, Davis
Hallym University Medical Center
Vanderbilt-Ingram Cancer Center
University of Alabama at Birmingham
Massachusetts General Hospital
Alliance for Clinical Trials in Oncology
Fox Chase Cancer Center
Stanford University
Roswell Park Cancer Institute
Royal Marsden NHS Foundation Trust
University of Pittsburgh
Hoffmann-La Roche
M.D. Anderson Cancer Center
NYU Langone Health
Hoffmann-La Roche
M.D. Anderson Cancer Center
GERCOR - Multidisciplinary Oncology Cooperative Group
National Cancer Institute (NCI)
Hoffmann-La Roche
Duke University
Taipei Veterans General Hospital, Taiwan
Hoffmann-La Roche
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Soonchunhyang University Hospital